skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:053440/0178   Pages: 12
Recorded: 08/10/2020
Attorney Dkt #:17066.002
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 42
1
Patent #:
9809654
Issue Dt:
11/07/2017
Application #:
10529221
Filing Dt:
06/30/2006
Publication #:
US20060269540
Pub Dt:
11/30/2006
Title:
Targeted cd1d molecules
2
Patent #:
9382327
Issue Dt:
07/05/2016
Application #:
11869170
Filing Dt:
10/09/2007
Publication #:
US20090130089
Pub Dt:
05/21/2009
Title:
ANTI-CD20 ANTIBODIES AND METHODS OF USE
3
Patent #:
7919594
Issue Dt:
04/05/2011
Application #:
12030356
Filing Dt:
02/13/2008
Publication #:
US20080219971
Pub Dt:
09/11/2008
Title:
HUMAN ANTI-CD100 ANTIBODIES
4
Patent #:
9603922
Issue Dt:
03/28/2017
Application #:
12034737
Filing Dt:
02/21/2008
Publication #:
US20080254045
Pub Dt:
10/16/2008
Title:
Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules
5
Patent #:
8496938
Issue Dt:
07/30/2013
Application #:
12776187
Filing Dt:
05/07/2010
Publication #:
US20100285036
Pub Dt:
11/11/2010
Title:
ANTI-CD100 NEUTRALIZING ANTIBODIES AND METHODS OF USING THE SAME
6
Patent #:
8816058
Issue Dt:
08/26/2014
Application #:
13517807
Filing Dt:
06/14/2012
Publication #:
US20120270268
Pub Dt:
10/25/2012
Title:
Polynucleotides Encoding Anti-CD100 Antibodies or Antigen-binding Fragments Thereof
7
Patent #:
8834883
Issue Dt:
09/16/2014
Application #:
13703947
Filing Dt:
02/28/2013
Publication #:
US20130202615
Pub Dt:
08/08/2013
Title:
ANTI-VEGF ANTIBODIES AND USES THEREOF
8
Patent #:
8790652
Issue Dt:
07/29/2014
Application #:
13707299
Filing Dt:
12/06/2012
Publication #:
US20130142810
Pub Dt:
06/06/2013
Title:
USE OF THE COMBINATION OF SEMAPHORIN-4D INHIBITORY MOLECULES AND VEGF INHIBITORY MOLECULES TO INHIBIT ANGIOGENESIS
9
Patent #:
9605055
Issue Dt:
03/28/2017
Application #:
13797048
Filing Dt:
03/12/2013
Publication #:
US20140072578
Pub Dt:
03/13/2014
Title:
Anti-CD100 Antibodies and Methods of Using the Same
10
Patent #:
9676840
Issue Dt:
06/13/2017
Application #:
13800713
Filing Dt:
03/13/2013
Publication #:
US20130274449
Pub Dt:
10/17/2013
Title:
Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11
Patent #:
9963504
Issue Dt:
05/08/2018
Application #:
13820278
Filing Dt:
04/19/2013
Publication #:
US20150050287
Pub Dt:
02/19/2015
Title:
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
12
Patent #:
9090709
Issue Dt:
07/28/2015
Application #:
13828506
Filing Dt:
03/14/2013
Publication #:
US20140099334
Pub Dt:
04/10/2014
Title:
ANTI-SEMA4D ANTIBODIES AND EPITOPES
13
Patent #:
10494440
Issue Dt:
12/03/2019
Application #:
13842523
Filing Dt:
03/15/2013
Publication #:
US20130302320
Pub Dt:
11/14/2013
Title:
Use of Semaphorin-4D Binding Molecules to Promote Neurogenesis Following Stroke
14
Patent #:
9708601
Issue Dt:
07/18/2017
Application #:
13844388
Filing Dt:
03/15/2013
Publication #:
US20130288927
Pub Dt:
10/31/2013
Title:
Fusion Proteins to Facilitate Selection of Cells Infected with Specific Immunoglobulin Gene Recombinant Vaccinia Virus
15
Patent #:
9447191
Issue Dt:
09/20/2016
Application #:
14117254
Filing Dt:
06/25/2014
Publication #:
US20140303358
Pub Dt:
10/09/2014
Title:
Osteogenesis Promoter
16
Patent #:
9243068
Issue Dt:
01/26/2016
Application #:
14310848
Filing Dt:
06/20/2014
Publication #:
US20150044219
Pub Dt:
02/12/2015
Title:
Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases
17
Patent #:
9890213
Issue Dt:
02/13/2018
Application #:
14382410
Filing Dt:
09/02/2014
Publication #:
US20150125467
Pub Dt:
05/07/2015
Title:
METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES
18
Patent #:
9512224
Issue Dt:
12/06/2016
Application #:
14511679
Filing Dt:
10/10/2014
Publication #:
US20150104462
Pub Dt:
04/16/2015
Title:
Use of Semaphorin-4D Binding Molecules for Treatment of Atherosclerosis
19
Patent #:
9598495
Issue Dt:
03/21/2017
Application #:
14519965
Filing Dt:
10/21/2014
Publication #:
US20150110800
Pub Dt:
04/23/2015
Title:
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
20
Patent #:
9249227
Issue Dt:
02/02/2016
Application #:
14753882
Filing Dt:
06/29/2015
Publication #:
US20150353641
Pub Dt:
12/10/2015
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
21
Patent #:
9790271
Issue Dt:
10/17/2017
Application #:
14765162
Filing Dt:
07/31/2015
Publication #:
US20150368332
Pub Dt:
12/24/2015
Title:
METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS
22
Patent #:
9828435
Issue Dt:
11/28/2017
Application #:
14892099
Filing Dt:
11/18/2015
Publication #:
US20160115240
Pub Dt:
04/28/2016
Title:
Use of Antibodies or Antigen-Binding Fragments Thereof that Specifically Bind Semaphorin-4D to Increase Tumor Infiltrating Leukocyte Frequency
23
Patent #:
9701958
Issue Dt:
07/11/2017
Application #:
14977067
Filing Dt:
12/21/2015
Publication #:
US20160152971
Pub Dt:
06/02/2016
Title:
METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMUNOGLOBULIN SUBUNITS
24
Patent #:
10301393
Issue Dt:
05/28/2019
Application #:
15173186
Filing Dt:
06/03/2016
Publication #:
US20160376372
Pub Dt:
12/29/2016
Title:
METHOD OF TREATING MULTIPLE SCLEROSIS USING ANTI-CD20 ANTIBODIES
25
Patent #:
10385136
Issue Dt:
08/20/2019
Application #:
15465509
Filing Dt:
03/21/2017
Publication #:
US20170198053
Pub Dt:
07/13/2017
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
26
Patent #:
11274149
Issue Dt:
03/15/2022
Application #:
15581573
Filing Dt:
04/28/2017
Publication #:
US20170306017
Pub Dt:
10/26/2017
Title:
ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME
27
Patent #:
10662422
Issue Dt:
05/26/2020
Application #:
15619790
Filing Dt:
06/12/2017
Publication #:
US20170306318
Pub Dt:
10/26/2017
Title:
METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMUNOGLOBULIN SUBUNIT
28
Patent #:
10526414
Issue Dt:
01/07/2020
Application #:
15666133
Filing Dt:
08/01/2017
Publication #:
US20170335008
Pub Dt:
11/23/2017
Title:
USE OF ANTI-SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES
29
Patent #:
10829550
Issue Dt:
11/10/2020
Application #:
15953139
Filing Dt:
04/13/2018
Publication #:
US20180244764
Pub Dt:
08/30/2018
Title:
POLYNUCLEOTIDES ENCODING ANTI-CXCL13 ANTIBODIES
30
Patent #:
10577427
Issue Dt:
03/03/2020
Application #:
16091077
Filing Dt:
10/03/2018
Publication #:
US20190112388
Pub Dt:
04/18/2019
Title:
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
31
Patent #:
10640765
Issue Dt:
05/05/2020
Application #:
16384078
Filing Dt:
04/15/2019
Publication #:
US20190241889
Pub Dt:
08/08/2019
Title:
METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS
32
Patent #:
10550199
Issue Dt:
02/04/2020
Application #:
16384087
Filing Dt:
04/15/2019
Publication #:
US20190276556
Pub Dt:
09/12/2019
Title:
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
33
Patent #:
11078295
Issue Dt:
08/03/2021
Application #:
16392451
Filing Dt:
04/23/2019
Publication #:
US20190248914
Pub Dt:
08/15/2019
Title:
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASES
34
Patent #:
11534488
Issue Dt:
12/27/2022
Application #:
16433496
Filing Dt:
06/06/2019
Publication #:
US20190358321
Pub Dt:
11/28/2019
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAIN BARRIER PERMEABILITY
35
Patent #:
10800853
Issue Dt:
10/13/2020
Application #:
16460593
Filing Dt:
07/02/2019
Publication #:
US20190322757
Pub Dt:
10/24/2019
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
36
Patent #:
NONE
Issue Dt:
Application #:
16488123
Filing Dt:
08/22/2019
Publication #:
US20190383836
Pub Dt:
12/19/2019
Title:
EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
37
Patent #:
11572408
Issue Dt:
02/07/2023
Application #:
16496286
Filing Dt:
09/20/2019
Publication #:
US20210179708
Pub Dt:
06/17/2021
Title:
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT
38
Patent #:
11427634
Issue Dt:
08/30/2022
Application #:
16611209
Filing Dt:
11/05/2019
Publication #:
US20210032329
Pub Dt:
02/04/2021
Title:
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
39
Patent #:
10870707
Issue Dt:
12/22/2020
Application #:
16727151
Filing Dt:
12/26/2019
Publication #:
US20200216562
Pub Dt:
07/09/2020
Title:
INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOPED VIRIONS
40
Patent #:
NONE
Issue Dt:
Application #:
16832170
Filing Dt:
03/27/2020
Publication #:
US20200317788
Pub Dt:
10/08/2020
Title:
SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY
41
Patent #:
NONE
Issue Dt:
Application #:
16860217
Filing Dt:
04/28/2020
Publication #:
US20200299683
Pub Dt:
09/24/2020
Title:
METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EUKARYOTIC CELLS
42
Patent #:
11660330
Issue Dt:
05/30/2023
Application #:
16906713
Filing Dt:
06/19/2020
Publication #:
US20200397881
Pub Dt:
12/24/2020
Title:
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 THERAPY
Assignor
1
VACCINEX, INC.
Exec Dt:
08/03/2020
Assignee
1
3I, L.P.
140 BROADWAY, 38TH FLOOR
NEW YORK, NEW YORK 10005
Correspondence name and address
JOHN C. STELLABOTTE
1345 AVENUE OF THE AMERICAS, 11TH FLOOR
NEW YORK, NY 10105

Search Results as of: 06/11/2024 02:48 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT